141 related articles for article (PubMed ID: 2451472)
1. [Evaluation of transcatheter arterial embolization in terms of serum alpha-fetoprotein doubling time in hepatocellular carcinoma].
Kanno T; Harihara S; Kim K; Kimura S; Tamori A; Kuroki T; Mizoguchi Y; Kobayashi K; Monna T; Nakamura K
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):683-7. PubMed ID: 2451472
[TBL] [Abstract][Full Text] [Related]
2. Monitoring of lectin-reactive alpha-fetoproteins in patients with hepatocellular carcinoma treated using transcatheter arterial embolization.
Yamashita F; Tanaka M; Satomura S; Tanikawa K
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):627-33. PubMed ID: 8590157
[TBL] [Abstract][Full Text] [Related]
3. [Usefulness of partial splenic embolization (PSE) in hepatocellular carcinomas showing a risk of gastrointestinal bleeding after transcatheter arterial embolization (TAE)].
Ohmoto K; Yamamoto R; Yamamoto S; Ideguchi S; Saito I; Wada A; Takatori K; Ohumi T; Hino K; Hirano Y
Gan No Rinsho; 1989 May; 35(6):690-5. PubMed ID: 2542638
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with survival exceeding 5 years after transcatheter arterial embolization for hepatocellular carcinoma.
Yoshioka H; Sato M; Sonomura T; Terada M; Kishi K; Yoshikawa A
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-29-S6-37. PubMed ID: 9151914
[TBL] [Abstract][Full Text] [Related]
5. [Transcatheter arterial embolization with hepatic arterial induction of endogenous TNF in hepatocellular carcinoma].
Takekoshi H; Oyama R
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2845-8. PubMed ID: 2476966
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of transcatheter arterial embolization and one-shot chemotherapy in hepatocellular carcinoma.
Soga K; Nomoto M; Ichida T; Aoyagi Y; Ozaki T; Ichida F
Hepatogastroenterology; 1988 Jun; 35(3):116-20. PubMed ID: 2841214
[TBL] [Abstract][Full Text] [Related]
7. Time courses of PIVKA-II and AFP levels after hepatic artery embolization and hepatic artery infusion against hepatocellular carcinoma: relation between the time course and tumor necrosis.
Kishi K; Sonomura T; Mitsuzane K; Nishida N; Kimura M; Satoh M; Yamada R; Kodama N; Kinoshita M; Tanaka H
Radiat Med; 1992; 10(5):189-95. PubMed ID: 1279748
[TBL] [Abstract][Full Text] [Related]
8. Combination therapy with transcatheter arterial embolization and percutaneous ethanol injection for advanced hepatocellular carcinoma.
Koda M; Okamoto K; Miyoshi Y; Kato S; Murawaki Y; Horie Y; Suou T; Kawasaki H
Hepatogastroenterology; 1994 Feb; 41(1):25-9. PubMed ID: 8175109
[TBL] [Abstract][Full Text] [Related]
9. Serum interleukin 6 as a predicator of the therapeutic effect and adverse reactions after transcatheter arterial embolization.
Yamazaki H; Nishimoto N; Oi H; Matsushita M; Ogata A; Shima Y; Inoue T; Tang JT; Yoshizaki K; Kishimoto T
Cytokine; 1995 Feb; 7(2):191-5. PubMed ID: 7780039
[TBL] [Abstract][Full Text] [Related]
10. [The clinical course of nodular type hepatocellular carcinomas after transcatheter arterial embolization (TAE) therapy].
Suyama Y; Kitagawa Y; Horishi M; Shizumi Y; Yashige H; Fujii H; Miyoshi M
Gan No Rinsho; 1989 Aug; 35(9):983-9. PubMed ID: 2475651
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of nontumorous tissue damage by transcatheter arterial embolization for hepatocellular carcinoma.
Khan KN; Nakata K; Kusumoto Y; Shima M; Ishii N; Koji T; Nagataki S
Cancer Res; 1991 Oct; 51(20):5667-71. PubMed ID: 1717151
[TBL] [Abstract][Full Text] [Related]
12. [The change of hepatic energy status after transcatheter arterial embolization (TAE) for hepatocellular carcinoma--a study using 31P-MRS].
Taniguchi K; Kaminaga T; Sakon M; Umeshita K; Yamada T; Takeda Y; Higaki N; Aoki T; Ohzato H; Hasuike Y; Gotoh M; Murakami T; Nakamura H; Monden M
Gan To Kagaku Ryoho; 1997 Sep; 24(12):1632-4. PubMed ID: 9382494
[TBL] [Abstract][Full Text] [Related]
13. [Hepatic artery infusion chemotherapy with cisplatin and adriamycin in combination with angiotensin-II in the treatment of malignant liver tumors].
Morita S; Matsumoto S; Odani R
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):689-95. PubMed ID: 2451473
[TBL] [Abstract][Full Text] [Related]
14. Adrenal metastasis from hepatocellular carcinoma--report of a case.
Kitagawa Y; Tajika T; Kameoka N; Kanda Y; Watanabe T; Miura A; Teramoto T; Masai O; Onuma T
Hepatogastroenterology; 1996; 43(11):1383-6. PubMed ID: 8908578
[TBL] [Abstract][Full Text] [Related]
15. [Effectiveness of preoperative transcatheter arterial embolization for improved survival rates in patients with hepatocellular carcinomas (sandwich therapy using ethiodized oil, cisplatin and gelatin sponge].
Shibata T; Sasaki Y; Imaoka S; Yasuda T; Wada H; Ishikawa O; Ohigashi H; Fukuda I; Kabuto T; Hiratsuka M
Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2514-9. PubMed ID: 2843115
[TBL] [Abstract][Full Text] [Related]
16. Effects of transcatheter hepatic arterial embolization on coagulation and fibrinolysis in patients with hepatocellular carcinoma.
Sakon M; Kambayashi J; Taniguchi K; Yoshida T; Shiba E; Kawasaki T; Tsuji Y; Yukawa M; Murata K; Gotoh M
Am J Gastroenterol; 1991 Dec; 86(12):1800-3. PubMed ID: 1660219
[TBL] [Abstract][Full Text] [Related]
17. [Early determination of the effect of preoperative TAE by observation of serum AFP changes in patients with hepatocellular carcinoma].
Tomioka T; Tsuchiya R; Harada N; Tsunoda T; Izawa K; Yamaguchi T; Yamamoto K
Nihon Geka Gakkai Zasshi; 1987 Apr; 88(4):453-9. PubMed ID: 2438550
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial.
Akamatsu M; Yoshida H; Obi S; Sato S; Koike Y; Fujishima T; Tateishi R; Imamura M; Hamamura K; Teratani T; Shiina S; Ishikawa T; Omata M
Liver Int; 2004 Dec; 24(6):625-9. PubMed ID: 15566514
[TBL] [Abstract][Full Text] [Related]
19. [Transcatheter hepatic arterial chemoembolization using microencapsulated mitomycin C (MMCmc)].
Takano S; Fujii M; Tanaka T; Sakabe T; Yamaguchi T; Kamata R
Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2424-7. PubMed ID: 2458071
[TBL] [Abstract][Full Text] [Related]
20. [Combination of transcatheter arterial infusion of SMANCS and embolization (SMANCS-TAE) for hepatocellular carcinoma].
Hirashima N
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():125-32. PubMed ID: 9512700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
